share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Real-time News ·  Nov 25, 2022 08:08

Gainers

  • LifeStance Health Gr (NASDAQ:LFST) stock increased by 37.0% to $6.89 during Friday's pre-market session. The market value of their outstanding shares is at $2.5 billion.
  • Apexigen (NASDAQ:APGN) stock moved upwards by 36.76% to $2.79. The company's market cap stands at $62.9 million.
  • Cosmos Holdings (NASDAQ:COSM) stock rose 23.81% to $0.4. The market value of their outstanding shares is at $33.2 million.
  • Exagen (NASDAQ:XGN) stock rose 11.47% to $3.79. The market value of their outstanding shares is at $61.8 million.
  • Tenaya Therapeutics (NASDAQ:TNYA) stock rose 11.06% to $2.71. The market value of their outstanding shares is at $112.1 million.
  • Nutex Health (NASDAQ:NUTX) stock moved upwards by 10.57% to $1.15. The market value of their outstanding shares is at $747.2 million. The company's, Q3 earnings came out 4 days ago.

Losers

  • Spectrum Pharmaceuticals (NASDAQ:SPPI) stock declined by 15.1% to $0.36 during Friday's pre-market session. The market value of their outstanding shares is at $74.1 million.
  • ProKidney (NASDAQ:PROK) stock decreased by 13.22% to $8.34. The company's market cap stands at $513.2 million.
  • Venus Concept (NASDAQ:VERO) stock decreased by 8.43% to $0.32. The market value of their outstanding shares is at $21.6 million.
  • Calyxt (NASDAQ:CLXT) shares declined by 7.31% to $0.16. The company's market cap stands at $7.8 million.
  • SINTX Technologies (NASDAQ:SINT) stock fell 6.19% to $0.1. The market value of their outstanding shares is at $5.1 million.
  • OncoSec Medical (NASDAQ:ONCS) stock decreased by 5.64% to $3.52. The company's market cap stands at $6.3 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment